One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Serum neurofilament light chain predicts cognitive worsening in secondary progressive multiple sclerosis better than brain MRI measures
Lorenzo Gaetani Menno M Schoonheim
doi : 10.1177/13524585221122916
Volume 28 Issue 12, October 2022
Hemostatic factors in the pathogenesis of neuroinflammation in multiple sclerosis
Gianmarco Abbadessa Luigi Lavorgna Constantina Andrada Treaba Simona Bonavita Caterina Mainero
All anti-CD20 monoclonal antibodies have similar efficacy and safety risks: Yes
Bruce AC Cree
All anti-CD20 monoclonal antibodies have similar efficacy and risks: No
Finn Sellebjerg Jeppe Romme Christensen
All anti-CD20 monoclonal antibodies have similar efficacy and risks: Commentary
Ian Dimaandal Jaime Imitola
Acute myocardial infarction risk in multiple sclerosis and neuromyelitis optica spectrum disorder: A nationwide cohort study in South Korea
Eun Bin Cho Yohwan Yeo Jin-Hyung Jung Su-Min Jeong Kyungdo Han Jeong Hoon Yang Dong Wook Shin Ju-Hong Min
Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
Synne Brune Einar A H?gest?l Sigrid A de Rodez Benavent P?l Berg-Hansen Mona K Beyer Ingvild S?rum Leikfoss Steffan D Bos Piotr Sowa Cat
Retinal layer thinning as a biomarker of long-term disability progression in multiple sclerosis
Klaus Berek Harald Hegen Jakob Hocher Michael Auer Franziska Di Pauli Nik Krajnc Reinhard Angermann Robert Barket Anne Zinganell Katharina Riedl Florian Deisenhammer Thomas Berger Gabriel Bsteh
Clinically relevant profiles of myelin content changes in patients with multiple sclerosis: A multimodal and multicompartment imaging study
Andrea Lazzarotto Matteo Tonietto Emilie Poirion Marco Battaglini Raffaele Palladino Charline Benoit Vito AG Ricigliano Elisabeth Maillart Nicola De Stefano Bruno Stankoff Benedetta Bodini
Lesion size and shape in central vein sign assessment for multiple sclerosis diagnosis: An in vivo and postmortem MRI study
Omar Al-Louzi Sargis Manukyan Maxime Donadieu Martina Absinta Vijay Letchuman Brent Calabresi Parth Desai Erin S Beck Snehashis Roy Joan Ohayon Dzung L Pham Anish Thomas Steven Jacobson Irene Cortese Pavan K Auluck Govind Nair Pascal Sati Daniel S Reich
Grey-matter sodium concentration as an individual marker of multiple sclerosis severity
Adil Maarouf Bertrand Audoin Soraya Gherib Mohamed Mounir El Mendili Patrick Viout Fanelly Pariollaud Clémence Boutière Audrey Rico Maxime Guye Jean-Philippe Ranjeva Wafaa Zaaraoui Jean Pelletier
Serum neurofilament light and MRI predictors of cognitive decline in patients with secondary progressive multiple sclerosis: Analysis from the MS-STAT randomised controlled trial
Thomas Williams Carmen Tur Arman Eshaghi Anisha Doshi Dennis Chan Sophie Binks Henny Wellington Amanda Heslegrave Henrik Zetterberg Jeremy Chataway
Ocrelizumab reduces thalamic volume loss in patients with RMS and PPMS
Douglas L Arnold Till Sprenger Amit Bar-Or Jerry S Wolinsky Ludwig Kappos Link to ORCID Shannon Kolind Ulrike Bonati Stefano Magon Johan van Beek Harold Koendgen Oscar Bortolami Corrado Bernasconi Laura Gaetano Anthony Traboulsee
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients
Gisella Guerrera Alessandra Mandelli Annamaria Finardi Mario Orrico Silvia D’Orso Mario Picozza Maddalena Noviello Valeria Beretta Bruno Bonetti Massimiliano Calabrese Damiano Marastoni Nicola De Rossi Ruggero Capra Marco Salvetti Maria Chiara Buscarinu Matilde Inglese Antonio Uccelli Lucia Moiola Catarina Raposo Erwan Muros-Le Rouzic Rosetta Pedotti Massimo Filippi Chiara Bonini Luca Battistini Giovanna Borsellino Roberto Furlan
Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trial
Bruce AC Cree Krzysztof W Selmaj Lawrence Steinman Giancarlo Comi Amit Bar-Or Douglas L Arnold Hans-Peter Hartung Xavier Montalbán Eva K Havrdová James K Sheffield Neil Minton Chun-Yen Cheng Diego Silva Ludwig Kappos Jeffrey A Cohen
Summary metrics of memory subnetwork functional connectivity alterations in multiple sclerosis
Victoria M Leavitt Jordan D Dworkin Korhan Buyukturkoglu Claire S Riley Maureen Ritchey
Altered functional brain states predict cognitive decline 5 years after a clinically isolated syndrome
Ismail Koubiyr Tommy AA Broeders Mathilde Deloire Bruno Brochet Thomas Tourdias Jeroen JG Geurts Menno Michiel Schoonheim Aurélie Ruet
Estimating the impact of work difficulties, work self-efficacy and work psychological safety on MS-related work productivity loss
Barnabas Bessing Suzi B Claflin Bruce V Taylor Leigh Blizzard Cynthia A Honan Pieter van Dijk Andrea Kirk-Brown Ingrid van der Mei
